Erythro
Brand names,
Erythro
Analogs
- (2S,3S)-2-Amino-3-methylpentanoic acid
- (2S,3S)-a-Amino-b-methyl-n-valeric acid
- (2S,3S)-a-Amino-b-methylvaleric acid
- (S)-Isoleucine
- (S,S)-Isoleucine
- 2-Amino-3-methylvaleric acid
- 2S,3S-Isoleucine
- Isoleucine
- Isoleucine, L-
- L-(+)-Isoleucine
- L-Ile
- L-Isoleucine
- L-Isoleucine (JP14/USP)
- L-Norvaline, 3-methyl-, erythro-
- Pentanoic acid, 2-amino-3-methyl-, (2S,3S)-
- [S-(R*,R*)]-2-Amino-3-methylpentanoic acid
- erythro-L-Isoleucine
Erythro
Brand Names Mixture
Erythro
Chemical_Formula
C6H13N1O2
Erythro
RX_link
No information avaliable
Erythro
fda sheet
Erythro
msds (material safety sheet)
Erythro
Synthesis Reference
No information avaliable
Erythro
Molecular Weight
131.174 g/mol
Erythro
Melting Point
168-170 oC
Erythro
H2O Solubility
No information avaliable
Erythro
State
Solid
Erythro
LogP
-1.743
Erythro
Dosage Forms
Capsules, powder, tablets
Erythro
Indication
The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
Erythro
Pharmacology
They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert.
Erythro
Absorption
Absorbed from the small intestine by a sodium-dependent active-transport process
Erythro
side effects and Toxicity
Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs
Erythro
Patient Information
No information avaliable
Erythro
Organisms Affected
Humans and other mammals